Market Cap | 38.18M | P/E | - | EPS this Y | 49.00% | Ern Qtrly Grth | - |
Income | -22.92M | Forward P/E | -10.55 | EPS next Y | 30.60% | 50D Avg Chg | -14.00% |
Sales | 83.98M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -42.00% |
Dividend | N/A | Price/Book | 1.03 | EPS next 5Y | - | 52W High Chg | -65.00% |
Recommedations | 3.00 | Quick Ratio | 0.22 | Shares Outstanding | 20.82M | 52W Low Chg | 3.00% |
Insider Own | 27.48% | ROA | -9.22% | Shares Float | 15.17M | Beta | 0.45 |
Inst Own | 3.21% | ROE | -78.65% | Shares Shorted/Prior | 428.85K/632.58K | Price | 2.11 |
Gross Margin | 35.19% | Profit Margin | -27.72% | Avg. Volume | 79,306 | Target Price | - |
Oper. Margin | -34.18% | Earnings Date | Jul 9 | Volume | 10,685 | Change | -1.86% |
Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.
Alliance Global Partners | Neutral | Feb 15, 24 |
Alliance Global Partners | Buy | Aug 15, 23 |
National Alliance Securities | Buy | May 24, 23 |
EF Hutton | Buy | May 17, 23 |
EF Hutton | Buy | Feb 15, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
MARSHALL ALLAN | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Dec 14 | Buy | 0.95 | 12,916 | 12,270 | 2,767,249 | 12/20/23 |
MARSHALL ALLAN | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Dec 07 | Buy | 0.9439 | 90,001 | 84,952 | 2,754,333 | 12/07/23 |
MARSHALL ALLAN | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Dec 04 | Buy | 0.78 | 53,474 | 41,710 | 2,664,332 | 12/06/23 |
MARSHALL ALLAN | CHIEF EXECUTIVE OFFI.. CHIEF EXECUTIVE OFFICER | Dec 14 | Buy | 3.67 | 17,303 | 63,502 | 2,575,081 | 01/11/23 |
Salkind Gene | Director Director | Mar 30 | Buy | 4.00 | 125,000 | 500,000 | 125,000 | 04/01/22 |